EX-FILING FEES 4 tm2210471d1_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

Calculation of Filing Fee Tables

 

Form S-3

(Form Type)

 

Armata Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered(1)
    Proposed
Maximum
Offering
Price Per
Unit(2)
  Maximum
Aggregate
Offering
Price
  Fee Rate     Amount of
Registration
Fee
  Carry
Forward
Form Type
    Carry
Forward
File
Number
    Carry
Forward
Initial
effective
date
    Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
Fees to Be Paid   Equity   Common Stock, $0.01 par value per share   Rule 457(c)     2,121,213     $ 5.36 $ 11,369,702     .0000927     $ 1,053.98                          
Carry Forward Securities
Carry Forward Securities                                                                    
    Total Offering Amounts               $ 11,369,702           $ 1,053.98                          
    Total Fees Previously Paid                           $ 0.00                          
    Total Fee Offsets                           $ 0.00                          
    Net Fee Due                           $ 1,053.98                          

 

 

  (1) The Registrant is hereby registering for resale from time to time by the selling stockholder named herein of up to 2,121,213 shares of its common stock that were initially issued pursuant to the Securities Purchase Agreement, dated as of October 28, 2021, by and between the Registrant and the selling stockholders. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers an indeterminate number of shares of common stock that may be issued as a result of stock splits, stock dividends, or similar transactions.
  (2) Estimated solely for purposes of determining the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average high and low prices per share of the common stock as reported on the NYSE American on March 24, 2022, a date within five business days prior to the filing of this Registration Statement.